Ticker brief

PDSB

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
27
authors 14d
10
crowd 14d
+1.0σ

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-16 · now -0.50 (−1 bearish … +1 bullish)
Who spoke10
authorgradetrader scoresignalsmean sent
@OptionsFlowBossC·7+0.34
@PrismMarketViewC·5+0.36
@sunxliaoB-0.093+0.65
@wliangC-2.483+0.67
@DavidScottAdamsC-2.622+0.10
@AnthonySandfordC·2+0.05
@PrismDMA-2.762+0.50
@GreatstockpixC-1.401+0.25
@CapitalJcC-3.041+0.60
@TickeronC+1.531-0.50
Recent signals27of 27 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-16@Tickeron-0.50PDSB fell 11.15% following a weeks-long rally of more than 100%.·
2026-10-14@wliang+0.65Expresses a bullish Q4 biotechnology view and identifies several constructive breakout and trend setups.·
2026-10-14@sunxliao+0.55States prior resistance has flipped to support and the chart still looks good.·
2026-10-13@OptionsFlowBoss+0.40Lists unusual bullish options-volume multiples; capped at six tickers.·
2026-10-13@PrismDM+0.50Midday mover report gives exact gains, losses and prices for five stocks.·
2026-10-13@PrismMarketView+0.00Lists timestamped midday stock movers and percentage changes.·
2026-10-13@wliang+0.80Explicitly bullish on PDSB's breakout and the broader biotech theme for Q4.·
2026-10-13@sunxliao+0.70Calls PDSB a clean weekly setup and predicts it could be the next NAUT after a strong close.·
2026-10-12@wliang+0.55Expects biotech and named stocks to outperform through Q4 and says dips may be worth buying.·
2026-10-12@PrismMarketView+0.45Reports named intraday gainers and decliners with prices, percentage changes and trading volumes.·
2026-10-12@OptionsFlowBoss+0.25Reports unusual bullish options-volume multiples in five stocks.·
2026-10-12@sunxliao+0.70Added PDSB to the focused biotech watchlist near a multi-year breakout. — Explicitly adds PDSB while presenting a focused biotech watchlist and breakout thesis.·
2026-10-12@OptionsFlowBoss+0.00References PDSB open-interest changes shown in media.·
2026-10-11@OptionsFlowBoss+0.00Shares PDSB gamma heat zones without visible levels or direction.·
2026-10-09@OptionsFlowBoss+0.40Lists unusual bullish options-volume multiples; output is capped at six tickers.·
2026-10-09@PrismDM+0.50Reports quantified intraday moves across named medtech and fintech stocks.·
2026-10-09@PrismMarketView+0.35Reports intraday percentage moves for five small-cap stocks.·
2026-10-05@DavidScottAdams+0.00Tomorrow's momentum watchlist without a stated entry or direction.·
2026-10-05@AnthonySandford+0.00Reviews options activity in four names but offers no clear directional trade recommendation.·
2026-10-05@AnthonySandford+0.10Summarizes unusual options activity and positioning across six stocks without issuing trades.·
2026-10-05@PrismMarketView+0.50Quantifies daily index breadth, sector performance and the largest single-stock movers.·
2026-10-05@DavidScottAdams+0.20Lists five stocks on a power-hour watchlist without explicit entry intent.·
2026-10-05@CapitalJc+0.60Celebratory retrospective ticker call with unavailable linked context·
2026-10-05@Greatstockpix+0.25Reports that PDSB is having a large positive trading day.·
2026-10-05@OptionsFlowBoss+0.80Rocket emojis express strong PDSB bullishness.·
2026-10-05@OptionsFlowBoss+0.50Lists unusually bullish options-volume multiples midday.·
2026-10-05@PrismMarketView+0.50Lists intraday prices and percentage moves for the leading gainers and decliner.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.